| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Singapore, Singapore--(Newsfile Corp. - September 30, 2025) - Mobile-health Network Solutions (NASDAQ:MNDR) ("MNDR" or the "Company"), a leading AI-powered digital health platform, today announced the launch of Phi GPT, an AI engine developed exclusively for clinical care pathways and powers a closed-ecosystem health companion built into the Company's Health Operating System (HOS).
Unlike platforms that depend on external AI providers, this companion - named Aiko - is primarily backed by proprietary, end-to-end integration, with core AI developed in-house and operating exclusively within MNDR's ecosystem, ensuring minimal reliance on third-party AI, data sharing, or outside integrations.
As a result, patient queries with Aiko - on such matters as medication adherence, preventive measures, and general health - remain private; never shared externally, visible to other users, or used to train outside models.
Via its access to secure patient data, Aiko consistently provides users with safe, accurate, warm, and empathetic step-by-step guidance tailored to each patient's needs - including patients who are unwell, elderly, or overwhelmed.
Aiko is also multilingual and simple to use, supporting multiple languages and underserved communities across Southeast Asia and multiple global markets.
"With Phi GPT powering Aiko, we are uniting science and empathy into a single lifelong health companion," said Co-CEO Dr. Siaw Tung Yeng. "Patients will know Aiko as a trusted guide, while investors may soon witness Phi GPT as a proprietary, scalable AI engine likely to strengthen every revenue stream in MNDR's ecosystem."
MNDR's ownership and operation of Phi GPT, he added, reduces its costs and boosts its scalability.
Early feedback, he stated, from MNDR's user base indicates that Aiko's primary features are being well received. 70 percent of the companion's users reported that they prioritize empathetic, human-like interactions, while 65 percent said they want simple interfaces, and 80 percent seek personalized advice.
Market Opportunity:
Monetization Pathways:
"MNDR's mission is bold but clear: to make healthcare as simple and natural as talking to a trusted friend," said Dr. Siaw. "With Phi GPT as its core and Aiko as its human-like companion, MNDR is building a fully integrated Health Operating System that will deliver telemedicine, diagnostics, and IoT care from cradle to grave, across Southeast Asia and beyond."
Dr. Siaw said the launch of Phi GPT, which began yesterday to a limited number of users, will be rolled out to all users in Singapore within the next two weeks and to all global users within the next month.
Posted In: MNDR
